The Biotech Summit Austria 2026 will bring together companies, start-ups, research institutions, investors, and other stakeholders from the European life sciences industry in Innsbruck from October 13 to 14. The focus will be on new technologies, growth, financing, and international cooperation. Keynotes, panels, and workshops will address key topics along the biotech value chain – from research and company building to intellectual property and international scaling. For companies, the summit offers the opportunity to establish relevant contacts from business, research, and investment, and to explore new collaboration opportunities.
Program Highlights & Your Benefits:
-
- Keynotes, panels, and workshops: Gain insights into current challenges and developments along the biotech value chain.
- Scaling scientific innovations: Learn how scientific developments can be turned into successful business models.
- Financing and venture capital: Connect with investors and learn about financing opportunities.
- International patent and IP strategies: Explore questions related to international patent and intellectual property strategies.
- Growth and organizational development: Gain impulses for the further development of growing biotech companies.
- Artificial intelligence in the biotech venture environment: Learn about the use of AI in the biotech venture environment.
- European framework conditions and the EU Biotech Act: Gain insights into relevant European framework conditions for the biotech industry.
Target audience:
- Biotech and life science companies
- Start-ups and scale-ups
- Research institutions and spin-offs
- Investors and venture capital stakeholders
- Companies offering technologies and services for the biotech industry
- Decision-makers from innovation and location organizations